These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 11591541
1. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Chest; 2001 Oct; 120(4):1072-7. PubMed ID: 11591541 [Abstract] [Full Text] [Related]
2. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Ong CW, Lye DC, Khoo KL, Chua GS, Yeoh SF, Leo YS, Tambyah PA, Chua AC. Respirology; 2009 Nov; 14(8):1200-5. PubMed ID: 19909464 [Abstract] [Full Text] [Related]
3. Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report. Xu A, Zhu H, Gao B, Weng H, Ding Z, Li M, Weng X, He G. BMC Infect Dis; 2020 Jan 15; 20(1):45. PubMed ID: 31941459 [Abstract] [Full Text] [Related]
4. Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings. Iwasawa Y, Hosokawa N, Harada M, Hayano S, Shimizu A, Suzuki D, Nakashima K, Yaegashi M. Intern Med; 2019 Jan 15; 58(2):301-305. PubMed ID: 30210104 [Abstract] [Full Text] [Related]
5. Community-acquired Acinetobacter baumannii pneumonia. Bachoumas K, Lebert C, Lacherade JC, Reignier J. Med Mal Infect; 2015 Aug 15; 45(8):337-9. PubMed ID: 26141128 [No Abstract] [Full Text] [Related]
6. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study. Chen CT, Wang YC, Kuo SC, Shih FH, Chen TL, How CK, Yang YS, Lee YT. J Microbiol Immunol Infect; 2018 Oct 15; 51(5):629-635. PubMed ID: 28701266 [Abstract] [Full Text] [Related]
7. Case Report: Severe Community-Acquired Pneumonia in Réunion Island due to Acinetobacter baumannii. Rotini G, de Mangou A, Combe A, Jabot J, Puech B, Dangers L, Nativel M, Allou N, Miltgen G, Vidal C. Am J Trop Med Hyg; 2024 Jul 03; 111(1):136-140. PubMed ID: 38834085 [Abstract] [Full Text] [Related]
8. Predictors of mortality in Acinetobacter baumannii bacteremia. Chen HP, Chen TL, Lai CH, Fung CP, Wong WW, Yu KW, Liu CY. J Microbiol Immunol Infect; 2005 Apr 03; 38(2):127-36. PubMed ID: 15843858 [Abstract] [Full Text] [Related]
10. [Community-acquired Acinetobacter baumannii pneumonia]. Salas Coronas J, Cabezas Fernández T, Alvarez-Ossorio García de Soria R, Díez García F. Rev Clin Esp; 2003 Jun 03; 203(6):284-6. PubMed ID: 12783714 [Abstract] [Full Text] [Related]
11. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests. Jean SS, Hsieh TC, Hsu CW, Lee WS, Bai KJ, Lam C. J Microbiol Immunol Infect; 2016 Dec 03; 49(6):924-933. PubMed ID: 26341302 [Abstract] [Full Text] [Related]
12. Fulminant community-acquired pneumonia probably caused by Acinetobacter lwoffii. Toyoshima M, Chida K, Suda T. Respirology; 2010 Jul 03; 15(5):867-8. PubMed ID: 20546186 [Abstract] [Full Text] [Related]
13. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Chaari A, Mnif B, Bahloul M, Mahjoubi F, Chtara K, Turki O, Gharbi N, Chelly H, Hammami A, Bouaziz M. Int J Infect Dis; 2013 Dec 03; 17(12):e1225-8. PubMed ID: 24094525 [Abstract] [Full Text] [Related]
14. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Liang CA, Lin YC, Lu PL, Chen HC, Chang HL, Sheu CC. Clin Microbiol Infect; 2018 Aug 03; 24(8):908.e1-908.e7. PubMed ID: 29108947 [Abstract] [Full Text] [Related]
15. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Davis JS, McMillan M, Swaminathan A, Kelly JA, Piera KE, Baird RW, Currie BJ, Anstey NM. Chest; 2014 Oct 03; 146(4):1038-1045. PubMed ID: 24901292 [Abstract] [Full Text] [Related]
16. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Chest; 2006 Jan 03; 129(1):102-9. PubMed ID: 16424419 [Abstract] [Full Text] [Related]
17. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium? Jean SS, Hsieh TC, Lee WS, Hsueh PR, Hsu CW, Lam C. Medicine (Baltimore); 2018 Sep 03; 97(39):e12278. PubMed ID: 30278498 [Abstract] [Full Text] [Related]
19. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Iroezindu MO, Chima EI, Isiguzo GC, Mbata GC, Onyedum CC, Onyedibe KI, Okoli LE. Scand J Infect Dis; 2014 Dec 03; 46(12):875-87. PubMed ID: 25288384 [Abstract] [Full Text] [Related]
20. Community-acquired bacteraemic Acinetobacter pneumonia with survival. Achar KN, Johny M, Achar MN, Menon NK. Postgrad Med J; 1993 Dec 03; 69(818):934-7. PubMed ID: 8121870 [Abstract] [Full Text] [Related] Page: [Next] [New Search]